It has come to my attention coming from the compan
Post# of 148101
(Total Views: 676)
Posted On: 09/28/2024 4:17:22 AM
It has come to my attention coming from the company that the p = .057 was a direct comparison of leronlimab vs. Resmetirom.
Here was my reply on learning the news.
Cyder wanted an apology to him if I was wrong. This post is my mea culpa but I don't apologize to scumbags.
Here was my reply on learning the news.
Quote:
Why in the hell would they post it that way when it doesn't show statistical significance. In a larger trial it certainly would but we don't have a larger trial to reference. They should have just posted up leronlimab vs. placebo and Resmetirom vs. placebo to show that leronlimab was superior.
Cyder wanted an apology to him if I was wrong. This post is my mea culpa but I don't apologize to scumbags.
(19)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼